Galderma Research Site 02
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Investigator, Principle
NCT05198310: Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Completed
2
145
Europe, US, RoW
KPL-404, Placebo
Kiniksa Pharmaceuticals, Ltd.
Arthritis, Rheumatoid
02/24
05/24
THB335-101, NCT06425861: A First in Human Trial Evaluating THB335 in Healthy Participants

Recruiting
1
56
US
THB335 single dose, Single dose placebo, THB335 fasted/fed, Placebo fasted/fed, THB335 multiple dose, Multiple dose placebo
Third Harmonic Bio, Inc.
Healthy
03/25
03/25
NCT06372782: Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand

Active, not recruiting
N/A
90
RoW
Restylane Skinboosters Vital Lidocaine, Restylane Vital
Galderma R&D
Skin Aging of Dorsal Hands
06/24
08/24

Download Options